Literature DB >> 20004441

Minor versus major hepatic resection for small hepatocellular carcinoma (HCC) in cirrhotic patients: a 20-year experience.

Divya Dahiya1, Ting-Jung Wu, Chen-Fang Lee, Kun-Ming Chan, Wei-Chen Lee, Miin-Fun Chen.   

Abstract

BACKGROUND: The choice between minor versus major resection or anatomic versus nonantatomic resection for small (<5 cm) solitary hepatocellular carcinoma (HCC) in patients with cirrhosis is controversial. The aim of our study was to evaluate the long-term disease-free survival (DFS) and overall survival (OS) after minor or major hepatic resection for small solitary HCC in cirrhotic patients.
METHODS: Between January 1983 and December 2002, patients with solitary HCC of < or = 5 cm in size who had histologically proven liver cirrhosis and microscopically tumor-free margin were included. These selected patients underwent either minor (< or = 2 segments) or major (> or = 3 segments) hepatectomy.
RESULTS: In 373 patients, 259 underwent minor and 114 underwent major hepatectomy. Patients in the minor resection group had more severe underlying liver disease (P = .005). Therefore, only 29.3% received anatomic resection in the minor resection group in comparison with 72.8% in the major hepatectomy group (P = .0001). No difference was found in postoperative morbidity (P = .105), mortality (P =.222), intrahepatic recurrence (P = .742), and 5-year DFS and OS (31.6% vs 31.8%, P = .932 and 50.7% vs 44.0%, P = .114) in both groups. The type of operative resection was not found to be a significant factor affecting survival in univariate analysis, but the preoperative liver function (alanine aminotransferase [AST] or alanine aminotransferase [ALT], serum albumin, or Child-Pugh status), tumor characteristics (alpha-feto protein, size, and presence of daughter nodules), and blood transfusion were found to be independent factors that affect the DFS and OS in a multivariate analysis.
CONCLUSION: The severity of cirrhosis and tumor characteristics depicts long-term survival rather than the type of resection in HCC. Crown Copyright 2010. Published by Mosby, Inc. All rights reserved.

Entities:  

Mesh:

Year:  2009        PMID: 20004441     DOI: 10.1016/j.surg.2009.10.043

Source DB:  PubMed          Journal:  Surgery        ISSN: 0039-6060            Impact factor:   3.982


  52 in total

1.  Central Hepatectomy Still Plays an Important Role in Treatment of Early-Stage Centrally Located Hepatocellular Carcinoma.

Authors:  Chun-Han Chen; Tzu-Hao Huang; Cheng-Chih Chang; Wei-Feng Li; Ting-Lung Lin; Chih-Chi Wang
Journal:  World J Surg       Date:  2017-11       Impact factor: 3.352

2.  Anatomic resection of liver segments 6-8 for hepatocellular carcinoma.

Authors:  Chang-Ku Jia; Jie Weng; You-Ke Chen; Yu Fu
Journal:  World J Gastroenterol       Date:  2014-04-21       Impact factor: 5.742

3.  A standard definition of major hepatectomy: resection of four or more liver segments.

Authors:  Srinevas K Reddy; Andrew S Barbas; Ryan S Turley; Jennifer L Steel; Allan Tsung; J Wallis Marsh; David A Geller; Bryan M Clary
Journal:  HPB (Oxford)       Date:  2011-07       Impact factor: 3.647

4.  Robot-assisted parenchymal-sparing liver surgery including lesions located in the posterosuperior segments.

Authors:  Luciano Casciola; Alberto Patriti; Graziano Ceccarelli; Alberto Bartoli; Cecilia Ceribelli; Alessandro Spaziani
Journal:  Surg Endosc       Date:  2011-06-08       Impact factor: 4.584

Review 5.  Segmentectomy: is minimally invasive surgery going to change a liver dogma?

Authors:  Fulvio Calise; Antonio Giuliani; Loredana Sodano; Enrico Crolla; Paolo Bianco; Aldo Rocca; Antonio Ceriello
Journal:  Updates Surg       Date:  2015-07-22

6.  Impact of Glissonean pedicle approach for centrally located hepatocellular carcinoma in mongolia.

Authors:  Jigjidsuren Chinburen; Michele Gillet; Masakazu Yamamoto; Tsiiregzen Enkh-Amgalan; Erdenebileg Taivanbaatar; Chinbold Enkhbold; Puntsagdulam Natsagnyam
Journal:  Int Surg       Date:  2015-02

7.  Outcomes Following Resection of Hepatocellular Carcinoma in the Absence of Cirrhosis.

Authors:  Richard H Lewis; Evan S Glazer; David M Bittenbinder; Thomas O'Brien; Jeremiah L Deneve; David Shibata; Stephen W Behrman; Jason M Vanatta; Sanjaya K Satapathy; Paxton V Dickson
Journal:  J Gastrointest Cancer       Date:  2019-12

8.  Resection margin with anatomic or nonanatomic hepatectomy for liver metastasis from colorectal cancer.

Authors:  Yoshihiro Inoue; Michihiro Hayashi; Koji Komeda; Shinsuke Masubuchi; Masashi Yamamoto; Hidenori Yamana; Hajime Kayano; Tetsunosuke Shimizu; Mitsuhiro Asakuma; Fumitoshi Hirokawa; Yoshiharu Miyamoto; Atsushi Takeshita; Yuro Shibayama; Kazuhisa Uchiyama
Journal:  J Gastrointest Surg       Date:  2012-02-28       Impact factor: 3.452

9.  Cardiopulmonary exercise testing for predicting postoperative morbidity in patients undergoing hepatic resection surgery.

Authors:  Ramanathan Kasivisvanathan; Nima Abbassi-Ghadi; Andrew D M McLeod; Alex Oliver; Ravishankar Rao Baikady; Shaman Jhanji; Stephen Cone; Timothy Wigmore
Journal:  HPB (Oxford)       Date:  2015-05-21       Impact factor: 3.647

Review 10.  Liver surgery in cirrhosis and portal hypertension.

Authors:  Christina Hackl; Hans J Schlitt; Philipp Renner; Sven A Lang
Journal:  World J Gastroenterol       Date:  2016-03-07       Impact factor: 5.742

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.